Progress in treatment of later period non-small cell lung cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 142-143, 2007.
Artigo
em Chinês
| WPRIM
| ID: wpr-383991
ABSTRACT
The lung cancer outbreak takes the first place in the global malignant tumor outbreak,becoming mainly reason to make death.Non-small cell lung cancer accounts for 80% of lung cancer around,70%~80% has already belonged to a later period while diagnosing(Ⅲ~Ⅳ period),It is the recommendation mode for later period NSCLC that the chemotherapy and radio treatment to put.The solution of using DDP/CBP with taxanens/gemcitabine/vinorelbine can raise curative effect further.It is a new way to treat later period NSCLC that is to use targeted treatment drug.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Guia de Prática Clínica
Idioma:
Chinês
Revista:
Cancer Research and Clinic
Ano de publicação:
2007
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS